| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.18M | 83.18M | 75.31M | 65.89M | 60.66M | 55.81M |
| Gross Profit | 50.04M | 50.04M | 46.44M | -3.31M | -1.56M | 36.39M |
| EBITDA | 2.31M | 2.31M | 20.45M | 9.60M | 10.20M | 4.99M |
| Net Income | 2.39M | 2.39M | 3.56M | -5.14M | -910.00K | -6.20M |
Balance Sheet | ||||||
| Total Assets | 67.71M | 67.71M | 63.81M | 62.22M | 67.76M | 57.28M |
| Cash, Cash Equivalents and Short-Term Investments | 27.09M | 27.09M | 21.27M | 12.35M | 12.24M | 30.30M |
| Total Debt | 8.97M | 8.97M | 9.70M | 11.71M | 13.85M | 8.58M |
| Total Liabilities | 24.56M | 24.56M | 25.05M | 28.02M | 30.66M | 21.54M |
| Stockholders Equity | 43.15M | 43.15M | 38.76M | 34.20M | 37.10M | 35.74M |
Cash Flow | ||||||
| Free Cash Flow | 21.91M | 21.91M | 19.13M | -251.00K | -564.00K | -312.00K |
| Operating Cash Flow | 22.51M | 22.51M | 19.31M | 15.70M | 12.59M | 6.86M |
| Investing Cash Flow | -15.10M | -15.10M | -5.29M | -15.50M | -28.67M | -7.14M |
| Financing Cash Flow | -1.91M | -1.91M | -2.44M | -2.58M | -3.28M | 21.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | AU$154.70M | 62.96 | 5.84% | ― | 10.40% | -32.96% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$30.75M | -102.50 | -3.14% | ― | 2.98% | 93.55% | |
44 Neutral | AU$33.01M | -13.50 | ― | ― | 7.32% | 67.11% | |
41 Neutral | AU$49.25M | -6.90 | ― | ― | 21.82% | 6.83% | |
40 Underperform | AU$51.33M | -1.01 | -212.09% | ― | 9.14% | 65.30% |
Hipages Group Holdings Ltd has notified the market of the cessation of 39,703 performance rights (security code HPGAA) after they lapsed on 31 December 2025 because their conditions were not met or became incapable of being satisfied. The lapsing of these conditional rights marginally reduces the company’s pool of potential equity-based remuneration, signalling that certain performance or service hurdles tied to these rights were not achieved, but does not affect the existing ordinary share capital on issue.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
Ellerston Capital Limited has lodged a notice that it has ceased to be a substantial holder in hipages Group Holdings Ltd, following changes in its relevant interests in the company’s voting securities as of 16 December 2025. The investment manager clarified that the hipages shares referenced were held on behalf of third-party client accounts under its discretionary management, and that neither Ellerston nor its own shareholders or associates hold a direct interest in the shares, signalling a shift in hipages’ institutional shareholder base that may alter its register composition but does not directly affect its underlying operations.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
hipages Group Holdings Ltd. announced a change in the director’s interest notice, detailing that Director Kate Mills has acquired an additional 23,462 rights, bringing her total to 93,778 rights. This acquisition is part of an annual grant of Director Equity Entitlements valued at $30,000, which was approved by shareholders at the 2023 AGM. The rights vest immediately upon granting, reflecting the company’s commitment to aligning director interests with shareholder value.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
hipages Group Holdings Ltd announced the issuance of 23,462 unquoted securities under an employee incentive scheme. These securities are subject to transfer restrictions and will not be quoted on the ASX until the restrictions are lifted. This move is part of the company’s strategy to incentivize its employees, potentially enhancing workforce motivation and aligning employee interests with company performance.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
hipages Group Holdings Ltd. has announced a change in the director’s interest notice, specifically concerning Robert Eliahu Sharon-Zipser. The change involves the allocation of rights under the hipages Management Equity Plan, as approved at the company’s 2025 Annual General Meeting. This adjustment reflects a strategic move to align management interests with shareholder value, potentially impacting the company’s operational focus and stakeholder engagement.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
hipages Group Holdings Ltd. announced the issuance of 2,714,662 unquoted securities under an employee incentive scheme. These securities are subject to transfer restrictions and are not quoted on the ASX until the restrictions are lifted, indicating a strategic move to incentivize employees and align their interests with company performance.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
Hipages Group Holdings Ltd announced the issuance of 271,576 unquoted equity securities under an employee incentive scheme. These securities are subject to transfer restrictions and will not be quoted on the ASX until the restrictions are lifted, potentially impacting employee retention and aligning interests with company performance.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
hipages Group Holdings Ltd announced that all resolutions from their 2025 Annual General Meeting were successfully passed. This includes key resolutions such as the re-election of independent non-executive directors and the approval of equity entitlements for the CEO and Chair. The outcomes reflect strong shareholder support and are indicative of the company’s stable governance and strategic direction, which could positively impact its market position and stakeholder confidence.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.
hipages Group Holdings Ltd reported a successful fiscal year 2025, marked by a strategic transformation from a marketplace to a SaaS-enabled platform, achieving double-digit revenue growth and meeting its financial guidance for revenue growth, EBITDA margin, and free cash flow. The company emphasized its commitment to growth through disciplined capital management, maintaining a strong balance sheet with no debt and a cash balance of $26.9 million, and plans to invest in AI technologies to enhance user experience and operational efficiency, while also focusing on cyber resilience to protect customer trust.
The most recent analyst rating on (AU:HPG) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on hipages Group Holdings Ltd. stock, see the AU:HPG Stock Forecast page.